Dassault Systèmes Holding Life Sciences Day in New York: Opening Up a New World of Virtual Twin Experiences for Healthcare

VELIZY-VILLACOUBLAY, France — November 13^th, 2019 — (Euronext Paris: #13065, DSY.PA) is holding a Life Sciences Day for analysts and investors, today, Wednesday, November 13^th, 2019 starting at 09.00 am ET in New York. The event includes presentations by the senior executive management team. The sessions are being webcast live and will be available for replay by accessing /events/event-details/life-sciences-day.

Bernard Charlès, Dassault Systèmes’ Vice Chairman and Chief Executive Officer commented:

“Health is now core (with Life Sciences our second largest industry)  we have a simple dream: help health innovators power smarter therapeutics for healthier people. In the age of precision medicine and patient experiences, it is clear that the future of healthcare will be shaped by inclusive and multi-discipline platforms enabling virtual twin experiences for healthcare. We made virtual twins of cars and airplanes possible.  We will do the same for the human body.

“The 3DEXPERIENCE platform combines modeling, simulation, data science, AI, and collaboration in the virtual world to achieve sustainable innovation in Life Sciences. Today, Dassault Systèmes brings a new, unified, end-to-end approach to research and discovery, development, clinical testing, manufacturing and commercialization of new therapies and health technologies.

“From a customer perspective the opportunity is significant – with a potential reach to 4,500 pharmaceutical and biotech companies and over 50,000 medical devices companies.” 

Pascal Daloz, Dassault Systèmes’ Executive Vice President, CFO and Corporate Strategy Officer,

commented:

 “In June of 2018 we initiated our 2018-2023 plan to double our non-IFRS EPS, to a goal of about €6.00. From a revenue perspective, our key growth drivers include the 3DEXPERIENCE platform and industry solution experiences, our expanding global footprint bringing diversification and balance by industry and geography, and new usage opportunities with the Cloud. Complementing our key growth drivers, is the recent addition of Medidata Solutions following the completion of its acquisition on October 28^th, 2019.  Based upon our assessment of its growth opportunities between 2020 and 2023, we estimate that Medidata will contribute approximately €0.70 and, more importantly, will set in motion future growth potential beyond 2023.”  

Social media:

Connect with Dassault Systèmes on

For more information:

Dassault Systèmes’ industry solution experiences and showcase for the Life Sciences industry:

Dassault Systèmes’ 3DEXPERIENCE platform, 3D design software, 3D Digital Mock Up and Product Lifecycle Management (PLM) solutions:

###

About Dassault Systèmes

Dassault Systèmes, the 3DEXPERIENCE Company, provides business and people with virtual universes to imagine sustainable innovations.  Its world-leading solutions transform the way products are designed, produced, and supported.  Dassault Systèmes’ collaborative solutions foster social innovation, expanding possibilities for the virtual world to improve the real world.  The group brings value to over 250,000 customers of all sizes, in all industries, in more than 140 countries.  For more information, visit .

3DEXPERIENCE, the Compass logo and the 3DS logo, CATIA, SOLIDWORKS, ENOVIA, DELMIA, SIMULIA, GEOVIA, EXALEAD, 3D VIA, BIOVIA, NETVIBES and 3DEXCITE are registered trademarks of Dassault Systèmes or its subsidiaries in the US and/or other countries.

Dassault Systèmes Investor Relations Contacts

François-José Bordonado/Béatrix Martinez

 

+33 (0) 1 61 62 69 24/70 21

North America: Michele Katz

Dassault Systèmes Press Contacts

Victoire de Margerie



+33 (0)1 61 62 54 08

Arnaud Malherbe



+33 (0)1 61 62 87 73

Attachment